Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALL

Best Practice and Research: Clinical Haematology

Volumn 15, Issue 1, 2002, Pages 59-70

  Goulden, Nick ^a   Steward, Colin ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Acute lymphoblastic leukaemia; Bone marrow transplantation; Minimal residual disease (MRD); Relapsed acute lymphoblastic leukaemia; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; METHOTREXATE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGRAFT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CAUSE OF DEATH; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORRELATION FUNCTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MINIMAL RESIDUAL DISEASE; MORTALITY; PRIORITY JOURNAL; RECURRENCE RISK; SIDE EFFECT; TREATMENT OUTCOME; WHOLE BODY RADIATION; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; METHODOLOGY; PROGNOSIS; RECURRENT DISEASE; REMISSION; REVIEW; STEM CELL TRANSPLANTATION; ALLOGENEIC STEM CELL TRANSPLANTATION; CLINICAL PROTOCOL; IMMUNOTHERAPY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MEDICAL LITERATURE; TREATMENT INDICATION;

CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; NEOPLASM, RESIDUAL; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036009606     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2002.0185     Document Type: Article

References (20)

1. The role of unrelated bone-marrow transplantation in childhood acute leukaemia
2. Bone marrow transplantation for acute lymphoblastic leukaemia
3. Haemopoietic stem cell transplantation from unrelated donors
4. Advances in full haplotype mismatched transplants in acute leukaemia
5. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission
6. Unrelated transplants for children with acute lymphoblastic leukaemia
7. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission
8. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
9. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
10. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia positive acute lymphoblastic leukaemia
11. Relapsed lymphoblastic leukaemia in children: A continuing challenge
12. Medical Research Council Working Party on Childhood Leukaemia. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: The MRC UKALL X experience
13. Who may benefit from donor leukocyte infusions after allogeneic stem cell transplantation?
14. Minimal residual status as a predictor of relapse after allogeneic bone marrow transplant for children with acute lymphoblastic leukaemia
15. False positive residual disease assessment post-bone marrow transplant in acute lymphoblastic leukaemia
16. Royal College of Physicians of Edinburgh. Consensus conference on unrelated-donor bone marrow transplantation, October 29 & 30, 1996: Its use in leukemias and allied disorders
17. Minimal residual disease status prior to allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukaemia
18. Minimal residual disease in ALL prior to allogeneic stem cell transplantation
19. High level MRD pre SCT is not necessarily associated with relapse in ALL
20. Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation